Comparison of PET/CT imaging with [¹⁸F]FDOPA and cholecystokinin-2 receptor targeting [⁶⁸Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma

Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):935-936. doi: 10.1007/s00259-020-04963-z. Epub 2020 Aug 3.

Authors

Christian Uprimny^#¹, Elisabeth von Guggenberg^#², Anna Svirydenka², Renata Mikołajczak³, Alicja Hubalewska-Dydejczyk⁴, Irene Johanna Virgolini²

Affiliations

¹ Department of Nuclear Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. christian.uprimny@tirol-kliniken.at.
² Department of Nuclear Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
³ Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.
⁴ Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.

^# Contributed equally.

PMID: 32748048
DOI: 10.1007/s00259-020-04963-z

No abstract available

Publication types

Case Reports

MeSH terms

Carcinoma, Neuroendocrine* / diagnostic imaging
Gallium Radioisotopes
Humans
Organometallic Compounds*
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Receptor, Cholecystokinin B
Thyroid Neoplasms* / diagnostic imaging

Substances

Gallium Radioisotopes
Organometallic Compounds
Receptor, Cholecystokinin B